We are live on
!
Find out more
Nicholas Company Portfolio holdings
AUM
$5.47B
Turnover
6.8%
1-Year Est. Return
16.96%
This Fund
S&P 500
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
(+1.6%)
Cap. Flow
-$99.3M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$36.1M |
| 2 |
ADT Corp
ADT
|
+$34.9M |
| 3 |
Pfizer
PFE
|
+$27.7M |
| 4 |
Chubb
CB
|
+$19.3M |
| 5 |
Johnson Controls International
JCI
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$79.3M |
| 2 |
MCRS
MICROS SYSTEMS INC
MCRS
|
+$73.6M |
| 3 |
Motorola Solutions
MSI
|
+$51M |
| 4 |
Bausch Health
BHC
|
+$23.5M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.03% |
| 2 | Consumer Discretionary | 15.41% |
| 3 | Industrials | 15.12% |
| 4 | Financials | 11.91% |
| 5 | Technology | 8.75% |
Similar funds
SCM
Nicholas Company's Q2 2014 Portfolio in Review
As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
- Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
- Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
- Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
- Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
- Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
- Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.
Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.